Clinical Trial Update: 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing 6-month safety and benefit of ADVAIR in children aged 4-11 with asthma; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Advair (fluticasone propionate/salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2016-10-05